Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Lehmann

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Cancer Research|October 3, 2008
Senescence-associated exosome release from human prostate cancer cellsBrian D Lehmann, Matthew S Paine, Adam M Brooks, et al.
BMC Bioinformatics|October 18, 2014
Detection of internal exon deletion with exon DelYan Guo, Shilin Zhao, Brian D Lehmann, et al.
Frontiers in Genetics|September 9, 2021
LR Hunting: A Random Forest Based Cell-Cell Interaction Discovery Method for Single-Cell Gene Expression DataMin Lu, Yifan Sha, Tiago C Silva, et al.
Breast Cancer Research : BCR|June 26, 2010
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cellsJoshua A Bauer, Fei Ye, Clayton B Marshall, et al.
Plos One|May 13, 2015
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin TreatmentsKareem N Mohni, Petria S Thompson, Jessica W Luzwick, et al.
Cell Death & Disease|July 28, 2021
Tissue-specific expression of p73 and p63 isoforms in human tissuesClayton B Marshall, J Scott Beeler, Brian D Lehmann, et al.
Cancer Research|May 28, 2016
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other MalignanciesTimothy M Shaver, Brian D Lehmann, J Scott Beeler, et al.
Plos One|June 17, 2016
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy SelectionBrian D Lehmann, Bojana Jovanović, Xi Chen, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Targeting prostate cancer based on signal transduction and cell cycle pathwaysJohn T Lee, Brian D Lehmann, David M Terrian, et al.
Molecular Cancer Research : MCR|June 13, 2019
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver MutationsBrian D Lehmann, Timothy M Shaver, Douglas B Johnson, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Cancer Research|October 3, 2008
Senescence-associated exosome release from human prostate cancer cellsBrian D Lehmann, Matthew S Paine, Adam M Brooks, et al.
BMC Bioinformatics|October 18, 2014
Detection of internal exon deletion with exon DelYan Guo, Shilin Zhao, Brian D Lehmann, et al.
Frontiers in Genetics|September 9, 2021
LR Hunting: A Random Forest Based Cell-Cell Interaction Discovery Method for Single-Cell Gene Expression DataMin Lu, Yifan Sha, Tiago C Silva, et al.
Breast Cancer Research : BCR|June 26, 2010
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cellsJoshua A Bauer, Fei Ye, Clayton B Marshall, et al.
Plos One|May 13, 2015
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin TreatmentsKareem N Mohni, Petria S Thompson, Jessica W Luzwick, et al.
Cell Death & Disease|July 28, 2021
Tissue-specific expression of p73 and p63 isoforms in human tissuesClayton B Marshall, J Scott Beeler, Brian D Lehmann, et al.
Cancer Research|May 28, 2016
Diverse, Biologically Relevant, and Targetable Gene Rearrangements in Triple-Negative Breast Cancer and Other MalignanciesTimothy M Shaver, Brian D Lehmann, J Scott Beeler, et al.
Plos One|June 17, 2016
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy SelectionBrian D Lehmann, Bojana Jovanović, Xi Chen, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Targeting prostate cancer based on signal transduction and cell cycle pathwaysJohn T Lee, Brian D Lehmann, David M Terrian, et al.
Molecular Cancer Research : MCR|June 13, 2019
Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver MutationsBrian D Lehmann, Timothy M Shaver, Douglas B Johnson, et al.
Pageof 7